ReportWire

Tag: SEC Filings

  • Johnson & Johnson (NYSE:JNJ) Shares Sold by Burke & Herbert Bank & Trust Co.

    Johnson & Johnson (NYSE:JNJ) Shares Sold by Burke & Herbert Bank & Trust Co.

    Burke & Herbert Bank & Trust Co. reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 18.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 22,909 shares of the company’s stock after selling 5,164 shares during the quarter. Johnson & Johnson accounts for approximately 2.9% of Burke & Herbert Bank & Trust Co.’s investment portfolio, making the stock its 6th biggest holding. Burke & Herbert Bank & Trust Co.’s holdings in Johnson & Johnson were worth $3,568,000 at the end of the most recent quarter.

    Several other institutional investors and hedge funds have also made changes to their positions in the stock. BlackRock Inc. lifted its stake in shares of Johnson & Johnson by 1.4% during the first quarter. BlackRock Inc. now owns 201,491,567 shares of the company’s stock worth $31,231,193,000 after buying an additional 2,688,798 shares during the period. State Street Corp lifted its stake in shares of Johnson & Johnson by 1.1% during the second quarter. State Street Corp now owns 141,833,756 shares of the company’s stock worth $23,476,323,000 after buying an additional 1,568,633 shares during the period. Moneta Group Investment Advisors LLC raised its holdings in shares of Johnson & Johnson by 90,144.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 54,386,720 shares of the company’s stock worth $9,607,414,000 after purchasing an additional 54,326,454 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Johnson & Johnson by 2.0% during the second quarter. Geode Capital Management LLC now owns 49,697,798 shares of the company’s stock worth $8,203,608,000 after purchasing an additional 990,298 shares during the last quarter. Finally, Morgan Stanley raised its holdings in shares of Johnson & Johnson by 12.0% during the fourth quarter. Morgan Stanley now owns 42,224,521 shares of the company’s stock worth $7,458,962,000 after purchasing an additional 4,521,062 shares during the last quarter. 68.40% of the stock is currently owned by institutional investors and hedge funds.

    Analyst Ratings Changes

    Several brokerages recently issued reports on JNJ. Cantor Fitzgerald reissued an “overweight” rating on shares of Johnson & Johnson in a report on Monday, December 18th. Wells Fargo & Company cut shares of Johnson & Johnson from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $170.00 to $163.00 in a report on Wednesday, December 13th. TheStreet cut shares of Johnson & Johnson from a “b” rating to a “c+” rating in a report on Friday, November 17th. Royal Bank of Canada reissued an “outperform” rating and set a $178.00 target price on shares of Johnson & Johnson in a report on Friday, December 1st. Finally, Raymond James cut their price objective on shares of Johnson & Johnson from $179.00 to $172.00 and set an “outperform” rating for the company in a report on Wednesday, October 18th. Eight research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Johnson & Johnson currently has an average rating of “Moderate Buy” and a consensus target price of $168.75.

    Read Our Latest Stock Report on JNJ

    Johnson & Johnson Stock Up 0.2 %

    Shares of NYSE JNJ opened at $156.61 on Friday. The company’s 50-day simple moving average is $152.48 and its 200-day simple moving average is $159.60. Johnson & Johnson has a 52-week low of $144.95 and a 52-week high of $180.93. The firm has a market cap of $377.00 billion, a price-to-earnings ratio of 11.63, a price-to-earnings-growth ratio of 3.20 and a beta of 0.57. The company has a quick ratio of 0.96, a current ratio of 1.21 and a debt-to-equity ratio of 0.37.

    Johnson & Johnson (NYSE:JNJ – Get Free Report) last announced its earnings results on Tuesday, October 17th. The company reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.52 by $0.14. Johnson & Johnson had a net margin of 36.32% and a return on equity of 37.14%. The business had revenue of $21.35 billion for the quarter, compared to analyst estimates of $21 billion. Equities analysts predict that Johnson & Johnson will post 9.96 EPS for the current fiscal year.

    Johnson & Johnson Announces Dividend

    The business also recently announced a quarterly dividend, which was paid on Tuesday, December 5th. Stockholders of record on Tuesday, November 21st were given a $1.19 dividend. The ex-dividend date of this dividend was Monday, November 20th. This represents a $4.76 annualized dividend and a dividend yield of 3.04%. Johnson & Johnson’s dividend payout ratio (DPR) is 35.34%.

    Johnson & Johnson Profile

    (Free Report)

    Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

    Further Reading

    Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).

    Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

    Receive News & Ratings for Johnson & Johnson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Johnson & Johnson and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Johnson & Johnson (NYSE:JNJ) Shares Acquired by Kingdom Financial Group LLC.

    Johnson & Johnson (NYSE:JNJ) Shares Acquired by Kingdom Financial Group LLC.

    Kingdom Financial Group LLC. lifted its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 258.0% during the third quarter, Holdings Channel reports. The fund owned 9,268 shares of the company’s stock after purchasing an additional 6,679 shares during the quarter. Johnson & Johnson comprises 1.4% of Kingdom Financial Group LLC.’s portfolio, making the stock its 17th biggest holding. Kingdom Financial Group LLC.’s holdings in Johnson & Johnson were worth $1,443,000 as of its most recent SEC filing.

    A number of other large investors have also made changes to their positions in the stock. Hibernia Wealth Partners LLC acquired a new stake in Johnson & Johnson in the 3rd quarter worth about $27,000. Atlantic Private Wealth LLC acquired a new stake in Johnson & Johnson in the 1st quarter worth about $32,000. FNY Investment Advisers LLC acquired a new stake in Johnson & Johnson in the 3rd quarter worth about $37,000. VitalStone Financial LLC acquired a new stake in Johnson & Johnson in the 2nd quarter worth about $48,000. Finally, Horizons Wealth Management lifted its stake in shares of Johnson & Johnson by 1,730.0% in the 2nd quarter. Horizons Wealth Management now owns 366 shares of the company’s stock valued at $61,000 after purchasing an additional 346 shares in the last quarter. Institutional investors and hedge funds own 68.40% of the company’s stock.

    Johnson & Johnson Trading Up 0.1 %

    NYSE:JNJ opened at $156.35 on Thursday. Johnson & Johnson has a 12-month low of $144.95 and a 12-month high of $180.93. The firm has a market capitalization of $376.38 billion, a P/E ratio of 11.61, a P/E/G ratio of 3.18 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.21 and a quick ratio of 0.96. The business has a 50 day simple moving average of $152.40 and a 200 day simple moving average of $159.62.

    Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its quarterly earnings data on Tuesday, October 17th. The company reported $2.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.52 by $0.14. Johnson & Johnson had a return on equity of 37.14% and a net margin of 36.32%. The business had revenue of $21.35 billion during the quarter, compared to analyst estimates of $21 billion. Equities research analysts predict that Johnson & Johnson will post 9.96 EPS for the current year.

    Johnson & Johnson Dividend Announcement

    The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 5th. Investors of record on Tuesday, November 21st were given a dividend of $1.19 per share. The ex-dividend date was Monday, November 20th. This represents a $4.76 dividend on an annualized basis and a yield of 3.04%. Johnson & Johnson’s dividend payout ratio is currently 35.34%.

    Analysts Set New Price Targets

    Several research firms have recently weighed in on JNJ. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Johnson & Johnson in a research note on Monday, December 18th. Wells Fargo & Company downgraded Johnson & Johnson from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $170.00 to $163.00 in a report on Wednesday, December 13th. Raymond James dropped their target price on Johnson & Johnson from $179.00 to $172.00 and set an “outperform” rating on the stock in a report on Wednesday, October 18th. UBS Group upgraded Johnson & Johnson from a “neutral” rating to a “buy” rating and raised their target price for the company from $167.00 to $180.00 in a report on Friday, December 1st. Finally, HSBC initiated coverage on Johnson & Johnson in a report on Wednesday, September 6th. They set a “hold” rating and a $175.00 price objective on the stock. Eight analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $168.75.

    Get Our Latest Research Report on Johnson & Johnson

    About Johnson & Johnson

    (Free Report)

    Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

    Featured Articles

    Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).

    Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

    Receive News & Ratings for Johnson & Johnson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Johnson & Johnson and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Vanguard Financials ETF (NYSEARCA:VFH) Shares Sold by IFP Advisors Inc

    Vanguard Financials ETF (NYSEARCA:VFH) Shares Sold by IFP Advisors Inc

    IFP Advisors Inc reduced its position in Vanguard Financials ETF (NYSEARCA:VFH – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,921 shares of the company’s stock after selling 157 shares during the quarter. IFP Advisors Inc’s holdings in Vanguard Financials ETF were worth $315,000 at the end of the most recent reporting period.

    Other hedge funds and other institutional investors have also modified their holdings of the company. Coastal Investment Advisors Inc. acquired a new stake in shares of Vanguard Financials ETF in the 2nd quarter worth $27,000. Key Financial Inc increased its stake in shares of Vanguard Financials ETF by 168.5% in the 2nd quarter. Key Financial Inc now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 214 shares during the last quarter. Larson Financial Group LLC purchased a new position in shares of Vanguard Financials ETF during the 2nd quarter worth $31,000. Fortis Capital Advisors LLC purchased a new position in shares of Vanguard Financials ETF during the 1st quarter worth $36,000. Finally, Patriot Investment Management Group Inc. purchased a new position in shares of Vanguard Financials ETF during the 4th quarter worth $37,000.

    Vanguard Financials ETF Trading Up 0.5 %

    NYSEARCA VFH opened at $92.09 on Wednesday. The stock has a market cap of $8.97 billion, a PE ratio of 12.10 and a beta of 1.09. Vanguard Financials ETF has a twelve month low of $73.25 and a twelve month high of $92.45. The stock has a fifty day simple moving average of $84.68 and a 200-day simple moving average of $83.33.

    Vanguard Financials ETF Company Profile

    (Free Report)

    Vanguard Financials ETF (the Fund) is an exchange-traded share class of Vanguard Financials Index Fund. The Fund employs a passive management or indexing investment approach designed to track the performance of the Morgan Stanley Capital International (MSCI) US Investable Market Financials Index, an index of stocks of large, medium and small United States companies in the financials sector, as classified under the Global Industry Classification Standard (GICS).

    Further Reading

    Want to see what other hedge funds are holding VFH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Financials ETF (NYSEARCA:VFH – Free Report).

    Institutional Ownership by Quarter for Vanguard Financials ETF (NYSEARCA:VFH)

    Receive News & Ratings for Vanguard Financials ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Vanguard Financials ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • IFP Advisors Inc Has $485,000 Stake in The Trade Desk, Inc. (NASDAQ:TTD)

    IFP Advisors Inc Has $485,000 Stake in The Trade Desk, Inc. (NASDAQ:TTD)

    IFP Advisors Inc trimmed its stake in The Trade Desk, Inc. (NASDAQ:TTD – Free Report) by 12.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,200 shares of the technology company’s stock after selling 906 shares during the period. IFP Advisors Inc’s holdings in Trade Desk were worth $485,000 as of its most recent SEC filing.

    A number of other large investors have also recently bought and sold shares of TTD. JPMorgan Chase & Co. grew its position in Trade Desk by 61.6% in the first quarter. JPMorgan Chase & Co. now owns 19,593,717 shares of the technology company’s stock valued at $1,193,453,000 after acquiring an additional 7,471,935 shares during the period. Norges Bank bought a new stake in Trade Desk in the fourth quarter valued at $100,508,000. 1832 Asset Management L.P. grew its holdings in shares of Trade Desk by 81.8% during the first quarter. 1832 Asset Management L.P. now owns 3,638,000 shares of the technology company’s stock worth $221,591,000 after purchasing an additional 1,636,700 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in shares of Trade Desk by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 13,367,719 shares of the technology company’s stock worth $599,275,000 after purchasing an additional 1,239,936 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in shares of Trade Desk by 74.2% during the first quarter. Bank of America Corp DE now owns 2,853,174 shares of the technology company’s stock worth $173,787,000 after purchasing an additional 1,215,662 shares during the last quarter. 68.23% of the stock is currently owned by institutional investors.

    Trade Desk Price Performance

    NASDAQ TTD opened at $73.43 on Tuesday. The firm has a market cap of $36.00 billion, a P/E ratio of 236.87, a P/E/G ratio of 7.49 and a beta of 1.59. The stock’s 50-day moving average is $71.64 and its 200-day moving average is $77.12. The Trade Desk, Inc. has a one year low of $41.20 and a one year high of $91.85.

    Trade Desk (NASDAQ:TTD – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The technology company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.05). The business had revenue of $493.27 million for the quarter, compared to analyst estimates of $486.94 million. Trade Desk had a return on equity of 7.38% and a net margin of 8.35%. Equities analysts anticipate that The Trade Desk, Inc. will post 0.42 EPS for the current year.

    Analyst Upgrades and Downgrades

    TTD has been the topic of several research analyst reports. New Street Research upgraded Trade Desk from a “sell” rating to a “neutral” rating in a report on Thursday, November 2nd. Stifel Nicolaus restated a “buy” rating and set a $91.00 target price on shares of Trade Desk in a report on Thursday, August 31st. StockNews.com initiated coverage on Trade Desk in a report on Thursday, October 5th. They set a “hold” rating on the stock. Loop Capital started coverage on Trade Desk in a report on Tuesday, October 24th. They set a “buy” rating and a $95.00 target price on the stock. Finally, Truist Financial reiterated a “buy” rating and issued a $80.00 price target on shares of Trade Desk in a report on Tuesday, November 28th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and twenty-three have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $83.88.

    View Our Latest Stock Analysis on TTD

    Insider Transactions at Trade Desk

    In related news, CFO Laura Schenkein sold 2,613 shares of Trade Desk stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $66.48, for a total value of $173,712.24. Following the sale, the chief financial officer now owns 660,009 shares of the company’s stock, valued at approximately $43,877,398.32. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Gokul Rajaram sold 2,999 shares of Trade Desk stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $77.39, for a total value of $232,092.61. Following the sale, the director now owns 39,311 shares of the company’s stock, valued at approximately $3,042,278.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Laura Schenkein sold 2,613 shares of Trade Desk stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $66.48, for a total value of $173,712.24. Following the completion of the sale, the chief financial officer now directly owns 660,009 shares in the company, valued at approximately $43,877,398.32. The disclosure for this sale can be found here. Insiders have sold a total of 359,864 shares of company stock valued at $28,301,307 over the last 90 days. 10.81% of the stock is owned by company insiders.

    About Trade Desk

    (Free Report)

    The Trade Desk, Inc operates as a technology company in the United States and internationally. The company operates a self-service cloud-based platform that allows buyers to plan, manage, optimize, and measure data-driven digital advertising campaigns across various ad formats and channels, including video, display, audio, digital-out-of-home, native, and social on various devices, such as computers, mobile devices, televisions, and streaming devices.

    See Also

    Want to see what other hedge funds are holding TTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Trade Desk, Inc. (NASDAQ:TTD – Free Report).

    Institutional Ownership by Quarter for Trade Desk (NASDAQ:TTD)

    Receive News & Ratings for Trade Desk Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Trade Desk and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • National Bank of Canada FI Purchases 46,266 Shares of Unum Group (NYSE:UNM)

    National Bank of Canada FI Purchases 46,266 Shares of Unum Group (NYSE:UNM)

    National Bank of Canada FI boosted its position in shares of Unum Group (NYSE:UNM – Free Report) by 464.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,220 shares of the financial services provider’s stock after purchasing an additional 46,266 shares during the period. National Bank of Canada FI’s holdings in Unum Group were worth $2,760,000 as of its most recent SEC filing.

    A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNM. Raleigh Capital Management Inc. purchased a new stake in shares of Unum Group in the second quarter worth approximately $27,000. Nordea Investment Management AB lifted its position in shares of Unum Group by 122.4% during the second quarter. Nordea Investment Management AB now owns 1,174,537 shares of the financial services provider’s stock worth $55,920,000 after purchasing an additional 646,428 shares during the last quarter. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of Unum Group by 4.4% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 5,607 shares of the financial services provider’s stock worth $267,000 after purchasing an additional 234 shares during the last quarter. NewSquare Capital LLC increased its stake in Unum Group by 4.9% in the 2nd quarter. NewSquare Capital LLC now owns 211,184 shares of the financial services provider’s stock worth $10,073,000 after buying an additional 9,932 shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp increased its stake in Unum Group by 45.6% in the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 108,882 shares of the financial services provider’s stock worth $5,194,000 after buying an additional 34,111 shares during the period. 79.37% of the stock is owned by hedge funds and other institutional investors.

    Insider Transactions at Unum Group

    In related news, EVP Puneet Bhasin sold 8,188 shares of the company’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $42.39, for a total transaction of $347,089.32. Following the transaction, the executive vice president now directly owns 54,318 shares of the company’s stock, valued at approximately $2,302,540.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.94% of the company’s stock.

    Unum Group Price Performance

    UNM opened at $44.94 on Monday. The firm has a market capitalization of $8.77 billion, a PE ratio of 7.26, a price-to-earnings-growth ratio of 0.83 and a beta of 0.98. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.29 and a quick ratio of 0.29. The business’s 50-day moving average is $44.75 and its two-hundred day moving average is $47.12. Unum Group has a 1 year low of $36.27 and a 1 year high of $52.15.

    Unum Group (NYSE:UNM – Get Free Report) last issued its quarterly earnings data on Tuesday, October 31st. The financial services provider reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.02. Unum Group had a net margin of 10.07% and a return on equity of 15.54%. The firm had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $3.11 billion. During the same quarter in the previous year, the firm earned $1.51 EPS. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. Research analysts anticipate that Unum Group will post 7.74 earnings per share for the current fiscal year.

    Unum Group declared that its board has initiated a share buyback program on Tuesday, October 31st that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the financial services provider to buy up to 5.2% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

    Unum Group Announces Dividend

    The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 17th. Stockholders of record on Friday, October 27th were issued a dividend of $0.365 per share. The ex-dividend date of this dividend was Thursday, October 26th. This represents a $1.46 annualized dividend and a dividend yield of 3.25%. Unum Group’s dividend payout ratio is presently 23.59%.

    Analyst Upgrades and Downgrades

    A number of brokerages have recently commented on UNM. Truist Financial reduced their target price on shares of Unum Group from $59.00 to $54.00 and set a “buy” rating on the stock in a research report on Friday, November 3rd. StockNews.com lowered Unum Group from a “buy” rating to a “hold” rating in a research report on Thursday. Jefferies Financial Group increased their price target on Unum Group from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday, September 14th. Finally, Morgan Stanley decreased their price objective on Unum Group from $54.00 to $53.00 and set an “equal weight” rating for the company in a report on Wednesday, November 15th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Unum Group has an average rating of “Moderate Buy” and an average target price of $54.50.

    Check Out Our Latest Report on Unum Group

    Unum Group Profile

    (Free Report)

    Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block and Corporate segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.

    See Also

    Institutional Ownership by Quarter for Unum Group (NYSE:UNM)

    Receive News & Ratings for Unum Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Unum Group and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Mount Yale Investment Advisors LLC Sells 1,096 Shares of NIKE, Inc. (NYSE:NKE)

    Mount Yale Investment Advisors LLC Sells 1,096 Shares of NIKE, Inc. (NYSE:NKE)

    Mount Yale Investment Advisors LLC reduced its position in NIKE, Inc. (NYSE:NKE – Free Report) by 33.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,134 shares of the footwear maker’s stock after selling 1,096 shares during the period. Mount Yale Investment Advisors LLC’s holdings in NIKE were worth $204,000 as of its most recent SEC filing.

    Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Marquette Asset Management LLC raised its stake in NIKE by 201.3% in the 2nd quarter. Marquette Asset Management LLC now owns 241 shares of the footwear maker’s stock valued at $27,000 after acquiring an additional 161 shares during the period. Tucker Asset Management LLC bought a new stake in shares of NIKE during the first quarter valued at about $29,000. Horizon Bancorp Inc. IN bought a new stake in shares of NIKE during the second quarter valued at about $29,000. Financial Freedom LLC bought a new stake in shares of NIKE during the fourth quarter valued at about $29,000. Finally, Worth Asset Management LLC bought a new stake in shares of NIKE during the first quarter valued at about $32,000. 63.42% of the stock is currently owned by institutional investors.

    NIKE Stock Performance

    NYSE:NKE opened at $108.03 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.84 and a current ratio of 2.87. The firm has a market cap of $164.41 billion, a PE ratio of 33.34, a price-to-earnings-growth ratio of 1.95 and a beta of 1.07. The business has a 50 day moving average price of $109.49 and a 200-day moving average price of $105.76. NIKE, Inc. has a fifty-two week low of $88.66 and a fifty-two week high of $131.31.

    NIKE (NYSE:NKE – Get Free Report) last announced its earnings results on Thursday, December 21st. The footwear maker reported $1.03 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.19. The company had revenue of $13.40 billion during the quarter, compared to the consensus estimate of $13.39 billion. NIKE had a return on equity of 34.97% and a net margin of 9.82%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.85 earnings per share. Equities research analysts predict that NIKE, Inc. will post 3.75 earnings per share for the current year.

    NIKE Increases Dividend

    The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Monday, December 4th will be issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Friday, December 1st. This is an increase from NIKE’s previous quarterly dividend of $0.34. NIKE’s dividend payout ratio is currently 45.68%.

    Analyst Upgrades and Downgrades

    Several brokerages have recently weighed in on NKE. Truist Financial decreased their price target on NIKE from $108.00 to $107.00 and set a “hold” rating on the stock in a research report on Friday. Piper Sandler decreased their price target on NIKE from $112.00 to $107.00 and set a “neutral” rating on the stock in a research report on Friday. Guggenheim reiterated a “buy” rating and set a $135.00 price target on shares of NIKE in a research report on Friday, September 22nd. Bank of America cut their price objective on NIKE from $125.00 to $110.00 in a report on Wednesday, September 20th. Finally, Evercore ISI started coverage on NIKE in a report on Tuesday, November 7th. They set an “outperform” rating and a $124.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and twenty-two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $123.94.

    Read Our Latest Stock Report on NKE

    Insider Activity at NIKE

    In other NIKE news, Director Robert Holmes Swan bought 13,072 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The stock was bought at an average price of $96.13 per share, for a total transaction of $1,256,611.36. Following the completion of the acquisition, the director now directly owns 18,005 shares in the company, valued at $1,730,820.65. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other NIKE news, EVP Monique S. Matheson sold 10,000 shares of the stock in a transaction on Monday, December 11th. The stock was sold at an average price of $119.00, for a total value of $1,190,000.00. Following the completion of the transaction, the executive vice president now owns 44,736 shares in the company, valued at $5,323,584. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert Holmes Swan acquired 13,072 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was purchased at an average price of $96.13 per share, with a total value of $1,256,611.36. Following the acquisition, the director now owns 18,005 shares of the company’s stock, valued at approximately $1,730,820.65. The disclosure for this purchase can be found here. 0.50% of the stock is owned by corporate insiders.

    NIKE Profile

    (Free Report)

    NIKE, Inc, together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.

    Featured Stories

    Institutional Ownership by Quarter for NIKE (NYSE:NKE)

    Receive News & Ratings for NIKE Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NIKE and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Johnson & Johnson (NYSE:JNJ) Shares Sold by M&R Capital Management Inc.

    Johnson & Johnson (NYSE:JNJ) Shares Sold by M&R Capital Management Inc.

    M&R Capital Management Inc. reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,635 shares of the company’s stock after selling 811 shares during the quarter. Johnson & Johnson makes up about 1.1% of M&R Capital Management Inc.’s investment portfolio, making the stock its 23rd biggest holding. M&R Capital Management Inc.’s holdings in Johnson & Johnson were worth $3,837,000 at the end of the most recent reporting period.

    Several other hedge funds and other institutional investors have also recently bought and sold shares of JNJ. Moneta Group Investment Advisors LLC grew its stake in Johnson & Johnson by 90,144.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 54,386,720 shares of the company’s stock worth $9,607,414,000 after buying an additional 54,326,454 shares during the last quarter. Norges Bank acquired a new position in shares of Johnson & Johnson during the fourth quarter valued at $4,609,399,000. Capital International Investors boosted its holdings in shares of Johnson & Johnson by 62.7% during the second quarter. Capital International Investors now owns 27,825,795 shares of the company’s stock valued at $4,605,627,000 after acquiring an additional 10,724,110 shares during the period. Journey Strategic Wealth LLC boosted its holdings in shares of Johnson & Johnson by 161,420.2% during the second quarter. Journey Strategic Wealth LLC now owns 7,276,483 shares of the company’s stock valued at $1,204,404,000 after acquiring an additional 7,271,978 shares during the period. Finally, Providence Capital Advisors LLC boosted its holdings in shares of Johnson & Johnson by 141,974.0% during the first quarter. Providence Capital Advisors LLC now owns 4,750,956 shares of the company’s stock valued at $30,651,000 after acquiring an additional 4,747,612 shares during the period. 68.40% of the stock is owned by institutional investors.

    Wall Street Analyst Weigh In

    JNJ has been the subject of several analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $178.00 price target on shares of Johnson & Johnson in a report on Friday, December 1st. TheStreet downgraded shares of Johnson & Johnson from a “b” rating to a “c+” rating in a report on Friday, November 17th. Morgan Stanley reduced their price target on shares of Johnson & Johnson from $174.00 to $171.00 and set an “equal weight” rating for the company in a report on Wednesday, October 18th. StockNews.com raised shares of Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 26th. Finally, Wells Fargo & Company downgraded shares of Johnson & Johnson from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $170.00 to $163.00 in a report on Wednesday, December 13th. Eight analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $168.75.

    Read Our Latest Stock Analysis on Johnson & Johnson

    Johnson & Johnson Price Performance

    JNJ stock opened at $156.46 on Wednesday. The company has a current ratio of 1.21, a quick ratio of 0.96 and a debt-to-equity ratio of 0.37. Johnson & Johnson has a one year low of $144.95 and a one year high of $180.93. The firm has a market capitalization of $376.64 billion, a PE ratio of 11.62, a P/E/G ratio of 3.17 and a beta of 0.57. The firm has a 50-day moving average of $152.51 and a two-hundred day moving average of $159.79.

    Johnson & Johnson (NYSE:JNJ – Get Free Report) last posted its quarterly earnings data on Tuesday, October 17th. The company reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.52 by $0.14. Johnson & Johnson had a net margin of 36.32% and a return on equity of 37.14%. The company had revenue of $21.35 billion during the quarter, compared to analyst estimates of $21 billion. On average, analysts forecast that Johnson & Johnson will post 9.97 earnings per share for the current year.

    Johnson & Johnson Announces Dividend

    The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 5th. Stockholders of record on Tuesday, November 21st were issued a $1.19 dividend. The ex-dividend date of this dividend was Monday, November 20th. This represents a $4.76 dividend on an annualized basis and a dividend yield of 3.04%. Johnson & Johnson’s dividend payout ratio is 35.34%.

    Johnson & Johnson Profile

    (Free Report)

    Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

    Featured Stories

    Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).

    Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

    Receive News & Ratings for Johnson & Johnson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Johnson & Johnson and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Covea Finance Has $71.01 Million Stock Holdings in Apple Inc. (NASDAQ:AAPL)

    Covea Finance Has $71.01 Million Stock Holdings in Apple Inc. (NASDAQ:AAPL)

    Covea Finance boosted its holdings in Apple Inc. (NASDAQ:AAPL – Free Report) by 1.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 414,740 shares of the iPhone maker’s stock after purchasing an additional 5,980 shares during the quarter. Apple comprises 4.0% of Covea Finance’s holdings, making the stock its 2nd largest holding. Covea Finance’s holdings in Apple were worth $71,008,000 as of its most recent SEC filing.

    A number of other hedge funds have also added to or reduced their stakes in AAPL. IFM Investors Pty Ltd grew its stake in Apple by 20.0% in the first quarter. IFM Investors Pty Ltd now owns 2,615,701 shares of the iPhone maker’s stock valued at $456,728,000 after acquiring an additional 435,891 shares during the period. Ironwood Wealth Management LLC. grew its stake in Apple by 0.4% in the first quarter. Ironwood Wealth Management LLC. now owns 240,628 shares of the iPhone maker’s stock valued at $42,016,000 after acquiring an additional 1,040 shares during the period. Markel Corp grew its stake in Apple by 0.7% in the first quarter. Markel Corp now owns 1,206,990 shares of the iPhone maker’s stock valued at $210,752,000 after acquiring an additional 8,450 shares during the period. Camden Capital LLC grew its stake in Apple by 9.2% in the first quarter. Camden Capital LLC now owns 156,364 shares of the iPhone maker’s stock valued at $27,305,000 after acquiring an additional 13,200 shares during the period. Finally, Harbor Island Capital LLC grew its stake in Apple by 0.3% in the first quarter. Harbor Island Capital LLC now owns 135,325 shares of the iPhone maker’s stock valued at $23,629,000 after acquiring an additional 400 shares during the period. 58.51% of the stock is currently owned by institutional investors.

    Insiders Place Their Bets

    In other Apple news, insider Chris Kondo sold 4,806 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $184.04, for a total transaction of $884,496.24. Following the sale, the insider now directly owns 34,687 shares of the company’s stock, valued at $6,383,795.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Timothy D. Cook sold 240,569 shares of the company’s stock in a transaction that occurred on Tuesday, October 3rd. The stock was sold at an average price of $172.50, for a total transaction of $41,498,152.50. Following the transaction, the chief executive officer now owns 3,280,053 shares of the company’s stock, valued at $565,809,142.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Chris Kondo sold 4,806 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $184.04, for a total value of $884,496.24. Following the transaction, the insider now directly owns 34,687 shares in the company, valued at approximately $6,383,795.48. The disclosure for this sale can be found here. Insiders have sold 573,352 shares of company stock valued at $101,734,290 over the last ninety days. 0.06% of the stock is owned by insiders.

    Wall Street Analyst Weigh In

    A number of equities research analysts have commented on AAPL shares. Wedbush raised their price objective on Apple from $240.00 to $250.00 and gave the company an “outperform” rating in a research note on Monday, December 11th. Tigress Financial lifted their target price on Apple from $225.00 to $240.00 and gave the stock a “strong-buy” rating in a report on Thursday, November 16th. Bank of America reaffirmed a “neutral” rating and issued a $173.00 price objective on shares of Apple in a report on Tuesday, October 24th. Morgan Stanley lifted their price objective on Apple from $210.00 to $220.00 and gave the stock an “overweight” rating in a report on Friday, December 8th. Finally, Jefferies Financial Group cut their price objective on Apple from $220.00 to $195.00 and set a “buy” rating for the company in a report on Tuesday, October 31st. Ten research analysts have rated the stock with a hold rating, twenty-five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $198.82.

    View Our Latest Stock Analysis on AAPL

    Apple Price Performance

    NASDAQ:AAPL opened at $195.89 on Tuesday. The company has a current ratio of 0.99, a quick ratio of 0.94 and a debt-to-equity ratio of 1.53. The company has a market capitalization of $3.05 trillion, a P/E ratio of 32.01, a P/E/G ratio of 2.74 and a beta of 1.31. Apple Inc. has a 12 month low of $124.17 and a 12 month high of $199.62. The business’s 50-day moving average is $184.40 and its 200 day moving average is $183.67.

    Apple (NASDAQ:AAPL – Get Free Report) last issued its quarterly earnings data on Thursday, November 2nd. The iPhone maker reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.07. Apple had a return on equity of 160.78% and a net margin of 25.31%. The company had revenue of $89.50 billion for the quarter, compared to analysts’ expectations of $89.34 billion. During the same period in the previous year, the firm posted $1.29 earnings per share. The firm’s revenue for the quarter was down .7% on a year-over-year basis. On average, equities research analysts forecast that Apple Inc. will post 6.56 earnings per share for the current fiscal year.

    Apple Dividend Announcement

    The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 16th. Shareholders of record on Monday, November 13th were paid a dividend of $0.24 per share. The ex-dividend date was Friday, November 10th. This represents a $0.96 annualized dividend and a yield of 0.49%. Apple’s payout ratio is currently 15.69%.

    Apple Profile

    (Free Report)

    Apple Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod.

    Read More

    Want to see what other hedge funds are holding AAPL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apple Inc. (NASDAQ:AAPL – Free Report).

    Institutional Ownership by Quarter for Apple (NASDAQ:AAPL)

    Receive News & Ratings for Apple Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Apple and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Rehmann Capital Advisory Group Makes New Investment in Intuit Inc. (NASDAQ:INTU)

    Rehmann Capital Advisory Group Makes New Investment in Intuit Inc. (NASDAQ:INTU)

    Rehmann Capital Advisory Group bought a new position in shares of Intuit Inc. (NASDAQ:INTU – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 622 shares of the software maker’s stock, valued at approximately $285,000.

    Several other institutional investors have also recently made changes to their positions in the stock. Bank Julius Baer & Co. Ltd Zurich raised its position in shares of Intuit by 99,673.1% in the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 157,291,233 shares of the software maker’s stock worth $72,069,270,000 after buying an additional 157,133,584 shares in the last quarter. State Street Corp raised its position in shares of Intuit by 1.8% in the second quarter. State Street Corp now owns 11,298,299 shares of the software maker’s stock worth $5,176,768,000 after buying an additional 198,646 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuit by 2.5% in the second quarter. Geode Capital Management LLC now owns 5,314,664 shares of the software maker’s stock worth $2,428,078,000 after buying an additional 131,586 shares in the last quarter. Brown Advisory Inc. raised its position in shares of Intuit by 3.0% in the second quarter. Brown Advisory Inc. now owns 3,536,542 shares of the software maker’s stock worth $1,620,408,000 after buying an additional 101,643 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Intuit by 42.5% in the fourth quarter. Morgan Stanley now owns 3,444,913 shares of the software maker’s stock worth $1,340,830,000 after buying an additional 1,027,752 shares in the last quarter. Hedge funds and other institutional investors own 82.63% of the company’s stock.

    Intuit Price Performance

    INTU opened at $608.51 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.25 and a current ratio of 1.25. Intuit Inc. has a 52-week low of $370.62 and a 52-week high of $617.61. The stock has a market capitalization of $170.35 billion, a PE ratio of 66.50, a price-to-earnings-growth ratio of 3.67 and a beta of 1.21. The stock’s 50 day moving average price is $542.29 and its 200-day moving average price is $508.58.

    Intuit (NASDAQ:INTU – Get Free Report) last released its quarterly earnings results on Tuesday, November 28th. The software maker reported $2.47 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.49. Intuit had a return on equity of 17.34% and a net margin of 17.53%. The company had revenue of $2.98 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the company posted $0.57 earnings per share. The firm’s revenue was up 14.7% on a year-over-year basis. On average, equities research analysts predict that Intuit Inc. will post 11.26 EPS for the current year.

    Intuit Announces Dividend

    The company also recently declared a quarterly dividend, which will be paid on Thursday, January 18th. Investors of record on Wednesday, January 10th will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, January 9th. This represents a $3.60 annualized dividend and a dividend yield of 0.59%. Intuit’s dividend payout ratio is presently 39.34%.

    Insider Activity at Intuit

    In related news, CEO Sasan K. Goodarzi sold 93,641 shares of Intuit stock in a transaction that occurred on Wednesday, December 6th. The stock was sold at an average price of $569.02, for a total transaction of $53,283,601.82. Following the sale, the chief executive officer now directly owns 65,324 shares in the company, valued at $37,170,662.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuit news, CEO Sasan K. Goodarzi sold 93,641 shares of the business’s stock in a transaction on Wednesday, December 6th. The stock was sold at an average price of $569.02, for a total value of $53,283,601.82. Following the sale, the chief executive officer now directly owns 65,324 shares of the company’s stock, valued at $37,170,662.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Mark P. Notarainni sold 358 shares of the business’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $511.29, for a total value of $183,041.82. Following the completion of the sale, the executive vice president now directly owns 869 shares in the company, valued at $444,311.01. The disclosure for this sale can be found here. Insiders have sold 98,940 shares of company stock worth $56,031,416 over the last ninety days. 2.90% of the stock is owned by corporate insiders.

    Analysts Set New Price Targets

    A number of brokerages recently issued reports on INTU. Credit Suisse Group increased their price objective on Intuit from $500.00 to $570.00 and gave the stock an “outperform” rating in a research report on Friday, August 25th. Argus lifted their price target on Intuit from $580.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, September 6th. Piper Sandler reaffirmed an “overweight” rating and set a $642.00 price target on shares of Intuit in a research note on Wednesday, November 29th. Evercore ISI raised their price objective on Intuit from $505.00 to $530.00 and gave the company an “outperform” rating in a report on Friday, August 25th. Finally, Oppenheimer boosted their target price on Intuit from $530.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. Four research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $587.67.

    Check Out Our Latest Stock Analysis on INTU

    Intuit Profile

    (Free Report)

    Intuit Inc provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax.

    Featured Articles

    Institutional Ownership by Quarter for Intuit (NASDAQ:INTU)

    Receive News & Ratings for Intuit Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuit and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Bokf Na Sells 11,823 Shares of EOG Resources, Inc. (NYSE:EOG)

    Bokf Na Sells 11,823 Shares of EOG Resources, Inc. (NYSE:EOG)

    Bokf Na trimmed its position in shares of EOG Resources, Inc. (NYSE:EOG – Free Report) by 24.4% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 36,603 shares of the energy exploration company’s stock after selling 11,823 shares during the quarter. Bokf Na’s holdings in EOG Resources were worth $4,189,000 at the end of the most recent quarter.

    Other institutional investors have also recently made changes to their positions in the company. VitalStone Financial LLC lifted its position in EOG Resources by 12,998.0% during the second quarter. VitalStone Financial LLC now owns 13,229 shares of the energy exploration company’s stock valued at $1,515,000 after buying an additional 13,128 shares during the period. Osaic Holdings Inc. lifted its position in EOG Resources by 18.8% during the 2nd quarter. Osaic Holdings Inc. now owns 259,510 shares of the energy exploration company’s stock valued at $29,731,000 after acquiring an additional 41,099 shares during the period. Orion Portfolio Solutions LLC lifted its position in EOG Resources by 80.2% during the 2nd quarter. Orion Portfolio Solutions LLC now owns 28,706 shares of the energy exploration company’s stock valued at $3,285,000 after acquiring an additional 12,774 shares during the period. Imprint Wealth LLC purchased a new position in EOG Resources during the 2nd quarter valued at about $1,087,000. Finally, Wambolt & Associates LLC lifted its position in EOG Resources by 5.9% during the 2nd quarter. Wambolt & Associates LLC now owns 4,180 shares of the energy exploration company’s stock valued at $478,000 after acquiring an additional 233 shares during the period. Institutional investors own 89.21% of the company’s stock.

    Wall Street Analysts Forecast Growth

    A number of research analysts recently issued reports on the stock. Mizuho lowered their price target on shares of EOG Resources from $158.00 to $150.00 and set a “buy” rating for the company in a research report on Wednesday, November 15th. JPMorgan Chase & Co. cut shares of EOG Resources from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $156.00 to $150.00 in a research report on Wednesday, December 6th. Stifel Nicolaus lifted their target price on shares of EOG Resources from $161.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, November 30th. Morgan Stanley cut shares of EOG Resources from an “overweight” rating to an “equal weight” rating and set a $134.00 target price for the company. in a report on Monday. Finally, Citigroup cut shares of EOG Resources from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $144.00 to $135.00 in a report on Monday, October 23rd. Nine equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $145.14.

    Get Our Latest Report on EOG Resources

    EOG Resources Trading Up 1.8 %

    Shares of NYSE:EOG opened at $120.60 on Friday. The stock has a market capitalization of $70.33 billion, a price-to-earnings ratio of 8.96, a PEG ratio of 0.34 and a beta of 1.44. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.10 and a current ratio of 2.43. The stock’s 50-day simple moving average is $125.21 and its two-hundred day simple moving average is $123.59. EOG Resources, Inc. has a 52-week low of $98.52 and a 52-week high of $137.95.

    EOG Resources (NYSE:EOG – Get Free Report) last announced its quarterly earnings data on Thursday, November 2nd. The energy exploration company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. EOG Resources had a net margin of 32.11% and a return on equity of 26.80%. The firm had revenue of $6.21 billion for the quarter, compared to the consensus estimate of $5.91 billion. Analysts expect that EOG Resources, Inc. will post 12.09 EPS for the current year.

    EOG Resources Increases Dividend

    The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be given a dividend of $0.91 per share. This is a positive change from EOG Resources’s previous quarterly dividend of $0.83. The ex-dividend date of this dividend is Tuesday, January 16th. This represents a $3.64 dividend on an annualized basis and a dividend yield of 3.02%. EOG Resources’s dividend payout ratio is currently 24.52%.

    EOG Resources Profile

    (Free Report)

    EOG Resources, Inc, together with its subsidiaries, explores for, develops, produces, and markets crude oil, and natural gas and natural gas liquids. Its principal producing areas are in New Mexico and Texas in the United States; and the Republic of Trinidad and Tobago. The company was formerly known as Enron Oil & Gas Company.

    Featured Articles

    Want to see what other hedge funds are holding EOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EOG Resources, Inc. (NYSE:EOG – Free Report).

    Institutional Ownership by Quarter for EOG Resources (NYSE:EOG)

    Receive News & Ratings for EOG Resources Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for EOG Resources and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Osaic Holdings Inc. Raises Holdings in Accenture plc (NYSE:ACN)

    Osaic Holdings Inc. Raises Holdings in Accenture plc (NYSE:ACN)

    Osaic Holdings Inc. grew its position in shares of Accenture plc (NYSE:ACN – Free Report) by 12.6% during the second quarter, Holdings Channel reports. The institutional investor owned 262,204 shares of the information technology services provider’s stock after purchasing an additional 29,421 shares during the quarter. Osaic Holdings Inc.’s holdings in Accenture were worth $80,980,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

    A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. raised its stake in shares of Accenture by 1.3% during the 1st quarter. BlackRock Inc. now owns 48,035,644 shares of the information technology services provider’s stock valued at $13,729,067,000 after purchasing an additional 634,462 shares during the period. State Street Corp raised its stake in shares of Accenture by 0.7% during the 2nd quarter. State Street Corp now owns 26,644,296 shares of the information technology services provider’s stock valued at $8,221,897,000 after purchasing an additional 190,412 shares during the period. Morgan Stanley increased its stake in Accenture by 14.9% in the 4th quarter. Morgan Stanley now owns 16,642,841 shares of the information technology services provider’s stock worth $4,440,976,000 after acquiring an additional 2,163,582 shares during the last quarter. Geode Capital Management LLC increased its stake in Accenture by 3.1% in the 2nd quarter. Geode Capital Management LLC now owns 11,816,701 shares of the information technology services provider’s stock worth $3,636,842,000 after acquiring an additional 353,521 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in Accenture by 21.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,535,663 shares of the information technology services provider’s stock worth $3,297,009,000 after acquiring an additional 2,060,646 shares during the last quarter. 70.42% of the stock is currently owned by institutional investors.

    Analyst Upgrades and Downgrades

    A number of brokerages have weighed in on ACN. Royal Bank of Canada restated an “outperform” rating and issued a $340.00 target price on shares of Accenture in a research note on Friday, September 29th. Barclays upped their target price on Accenture from $340.00 to $390.00 and gave the stock an “overweight” rating in a research note on Monday, September 11th. BMO Capital Markets decreased their target price on Accenture from $360.00 to $350.00 in a research note on Friday, September 29th. Robert W. Baird decreased their target price on Accenture from $332.00 to $322.00 and set a “neutral” rating on the stock in a research note on Friday, September 29th. Finally, TD Cowen reduced their price objective on Accenture from $312.00 to $300.00 and set a “market perform” rating on the stock in a research report on Friday, September 29th. Seven equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $337.26.

    View Our Latest Stock Report on Accenture

    Insider Transactions at Accenture

    In related news, CEO Julie Spellman Sweet sold 9,000 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $291.41, for a total transaction of $2,622,690.00. Following the completion of the transaction, the chief executive officer now owns 35,830 shares of the company’s stock, valued at approximately $10,441,220.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Julie Spellman Sweet sold 9,000 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $291.41, for a total transaction of $2,622,690.00. Following the completion of the transaction, the chief executive officer now owns 35,830 shares of the company’s stock, valued at approximately $10,441,220.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Ellyn Shook sold 5,250 shares of the firm’s stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $298.48, for a total value of $1,567,020.00. Following the transaction, the insider now directly owns 20,265 shares of the company’s stock, valued at approximately $6,048,697.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,334 shares of company stock valued at $10,939,027. Corporate insiders own 0.08% of the company’s stock.

    Accenture Price Performance

    Shares of ACN stock opened at $343.65 on Thursday. The stock has a market capitalization of $215.79 billion, a PE ratio of 31.91, a P/E/G ratio of 3.11 and a beta of 1.23. Accenture plc has a 1-year low of $242.80 and a 1-year high of $345.20. The business has a 50-day moving average of $317.95 and a 200 day moving average of $314.99.

    Accenture (NYSE:ACN – Get Free Report) last released its quarterly earnings data on Thursday, September 28th. The information technology services provider reported $2.71 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.06. Accenture had a return on equity of 29.74% and a net margin of 10.72%. The business had revenue of $15.99 billion during the quarter, compared to analysts’ expectations of $16.07 billion. During the same quarter last year, the business posted $2.60 EPS. The business’s revenue was up 3.6% on a year-over-year basis. Analysts anticipate that Accenture plc will post 12.2 EPS for the current year.

    Accenture Increases Dividend

    The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Thursday, October 12th were given a $1.29 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $5.16 annualized dividend and a dividend yield of 1.50%. This is a positive change from Accenture’s previous quarterly dividend of $1.12. Accenture’s dividend payout ratio is currently 47.91%.

    Accenture announced that its board has approved a share buyback program on Thursday, September 28th that allows the company to repurchase $4.00 billion in shares. This repurchase authorization allows the information technology services provider to buy up to 2% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

    Accenture Company Profile

    (Free Report)

    Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.

    Further Reading

    Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture plc (NYSE:ACN – Free Report).

    Institutional Ownership by Quarter for Accenture (NYSE:ACN)

    Receive News & Ratings for Accenture Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Accenture and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Montchanin Asset Management LLC Sells 400 Shares of Merck & Co., Inc. (NYSE:MRK)

    Montchanin Asset Management LLC Sells 400 Shares of Merck & Co., Inc. (NYSE:MRK)

    Montchanin Asset Management LLC reduced its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 7.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,733 shares of the company’s stock after selling 400 shares during the quarter. Montchanin Asset Management LLC’s holdings in Merck & Co., Inc. were worth $546,000 as of its most recent SEC filing.

    A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wahed Invest LLC raised its position in Merck & Co., Inc. by 0.3% in the 1st quarter. Wahed Invest LLC now owns 32,439 shares of the company’s stock worth $3,451,000 after purchasing an additional 91 shares during the period. Richard W. Paul & Associates LLC raised its position in Merck & Co., Inc. by 1.0% in the 2nd quarter. Richard W. Paul & Associates LLC now owns 9,389 shares of the company’s stock worth $1,083,000 after purchasing an additional 94 shares during the period. Financial Gravity Asset Management Inc. raised its position in Merck & Co., Inc. by 32.2% in the 2nd quarter. Financial Gravity Asset Management Inc. now owns 386 shares of the company’s stock worth $12,730,000 after purchasing an additional 94 shares during the period. Versant Capital Management Inc raised its position in Merck & Co., Inc. by 11.4% in the 2nd quarter. Versant Capital Management Inc now owns 926 shares of the company’s stock worth $107,000 after purchasing an additional 95 shares during the period. Finally, Providence Wealth Advisors LLC raised its position in Merck & Co., Inc. by 1.0% in the 1st quarter. Providence Wealth Advisors LLC now owns 9,711 shares of the company’s stock worth $1,106,000 after purchasing an additional 96 shares during the period. 74.59% of the stock is owned by hedge funds and other institutional investors.

    Insider Transactions at Merck & Co., Inc.

    In other news, EVP Richard R. Deluca sold 43,823 shares of Merck & Co., Inc. stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $105.03, for a total transaction of $4,602,729.69. Following the completion of the sale, the executive vice president now directly owns 111,764 shares in the company, valued at $11,738,572.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Richard R. Deluca sold 43,823 shares of Merck & Co., Inc. stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $105.03, for a total transaction of $4,602,729.69. Following the completion of the sale, the executive vice president now directly owns 111,764 shares in the company, valued at $11,738,572.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Johannes Jacobus Oosthuizen sold 2,081 shares of Merck & Co., Inc. stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $102.38, for a total transaction of $213,052.78. Following the sale, the insider now owns 18,191 shares of the company’s stock, valued at $1,862,394.58. The disclosure for this sale can be found here. Insiders own 0.20% of the company’s stock.

    Merck & Co., Inc. Price Performance

    Shares of MRK opened at $104.36 on Wednesday. The company has a market cap of $264.45 billion, a price-to-earnings ratio of 57.98, a price-to-earnings-growth ratio of 8.78 and a beta of 0.34. Merck & Co., Inc. has a twelve month low of $96.36 and a twelve month high of $119.65. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.82. The company has a 50 day moving average of $103.07 and a two-hundred day moving average of $106.71.

    Merck & Co., Inc. (NYSE:MRK – Get Free Report) last announced its earnings results on Thursday, October 26th. The company reported $2.13 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.19. The company had revenue of $16 billion during the quarter, compared to the consensus estimate of $15.30 billion. Merck & Co., Inc. had a net margin of 7.77% and a return on equity of 18.26%. Merck & Co., Inc.’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the firm earned $1.85 earnings per share. As a group, analysts predict that Merck & Co., Inc. will post 1.37 earnings per share for the current fiscal year.

    Merck & Co., Inc. Increases Dividend

    The company also recently announced a quarterly dividend, which will be paid on Monday, January 8th. Shareholders of record on Friday, December 15th will be paid a $0.77 dividend. This represents a $3.08 annualized dividend and a yield of 2.95%. This is an increase from Merck & Co., Inc.’s previous quarterly dividend of $0.73. The ex-dividend date is Thursday, December 14th. Merck & Co., Inc.’s dividend payout ratio (DPR) is 162.22%.

    Wall Street Analysts Forecast Growth

    MRK has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $135.00 target price on shares of Merck & Co., Inc. in a research report on Wednesday, November 29th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Merck & Co., Inc. in a research report on Thursday, November 9th. They set a “buy” rating and a $115.00 target price on the stock. BMO Capital Markets raised shares of Merck & Co., Inc. from a “market perform” rating to an “outperform” rating and set a $132.00 target price on the stock in a research report on Friday, October 27th. Truist Financial reaffirmed a “buy” rating and set a $122.00 target price on shares of Merck & Co., Inc. in a research report on Friday, October 6th. Finally, Morgan Stanley raised their target price on shares of Merck & Co., Inc. from $115.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Friday, October 27th. Five research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $125.14.

    View Our Latest Stock Report on Merck & Co., Inc.

    Merck & Co., Inc. Profile

    (Free Report)

    Merck & Co, Inc operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.

    Read More

    Institutional Ownership by Quarter for Merck & Co., Inc. (NYSE:MRK)

    Receive News & Ratings for Merck & Co. Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Merck & Co. Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Guggenheim Capital LLC Has $675,000 Stock Holdings in Semtech Co. (NASDAQ:SMTC)

    Guggenheim Capital LLC Has $675,000 Stock Holdings in Semtech Co. (NASDAQ:SMTC)

    Guggenheim Capital LLC grew its stake in shares of Semtech Co. (NASDAQ:SMTC – Free Report) by 58.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,520 shares of the semiconductor company’s stock after purchasing an additional 9,792 shares during the period. Guggenheim Capital LLC’s holdings in Semtech were worth $675,000 as of its most recent filing with the Securities and Exchange Commission.

    A number of other institutional investors and hedge funds also recently made changes to their positions in SMTC. Neo Ivy Capital Management acquired a new position in Semtech during the 2nd quarter worth approximately $41,000. Cerity Partners LLC bought a new stake in shares of Semtech during the first quarter valued at approximately $2,312,000. Captrust Financial Advisors raised its position in shares of Semtech by 186.5% during the first quarter. Captrust Financial Advisors now owns 1,020 shares of the semiconductor company’s stock worth $71,000 after purchasing an additional 664 shares during the period. Point72 Hong Kong Ltd bought a new position in shares of Semtech in the 1st quarter worth $84,000. Finally, Covestor Ltd grew its position in Semtech by 123.9% in the 1st quarter. Covestor Ltd now owns 1,397 shares of the semiconductor company’s stock valued at $97,000 after purchasing an additional 773 shares during the period.

    Insider Activity at Semtech

    In other Semtech news, SVP Michael W. Rodensky sold 18,227 shares of the firm’s stock in a transaction on Thursday, September 28th. The stock was sold at an average price of $25.50, for a total value of $464,788.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Semtech news, SVP Michael W. Rodensky sold 18,227 shares of the stock in a transaction dated Thursday, September 28th. The shares were sold at an average price of $25.50, for a total transaction of $464,788.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Paul V. Walsh, Jr. bought 20,000 shares of Semtech stock in a transaction dated Monday, September 18th. The stock was acquired at an average price of $24.83 per share, with a total value of $496,600.00. Following the purchase, the director now directly owns 20,888 shares of the company’s stock, valued at $518,649.04. The disclosure for this purchase can be found here. 1.20% of the stock is owned by company insiders.

    Semtech Trading Up 16.3 %

    NASDAQ SMTC opened at $19.42 on Friday. The business’s fifty day moving average is $17.68 and its 200-day moving average is $22.58. The company has a debt-to-equity ratio of 3.63, a current ratio of 1.96 and a quick ratio of 1.40. The stock has a market capitalization of $1.25 billion, a price-to-earnings ratio of -2.83 and a beta of 1.72. Semtech Co. has a one year low of $13.13 and a one year high of $35.18.

    Semtech (NASDAQ:SMTC – Get Free Report) last announced its quarterly earnings data on Wednesday, December 6th. The semiconductor company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.17. Semtech had a negative net margin of 53.62% and a positive return on equity of 2.94%. The business had revenue of $200.90 million for the quarter, compared to analyst estimates of $200.55 million. During the same quarter in the previous year, the firm posted $0.60 earnings per share. The company’s revenue for the quarter was up 13.1% on a year-over-year basis. Equities research analysts predict that Semtech Co. will post -0.71 EPS for the current year.

    Analyst Ratings Changes

    Several research firms have weighed in on SMTC. Summit Insights upgraded shares of Semtech from a “hold” rating to a “buy” rating in a report on Thursday, September 14th. Stifel Nicolaus dropped their price target on shares of Semtech from $24.00 to $22.00 and set a “buy” rating on the stock in a research report on Thursday. TheStreet lowered Semtech from a “c-” rating to a “d” rating in a report on Thursday, September 14th. Benchmark raised Semtech from a “hold” rating to a “buy” rating and set a $30.00 price objective for the company in a research note on Thursday, October 19th. Finally, Craig Hallum cut their target price on Semtech from $35.00 to $30.00 and set a “buy” rating on the stock in a research report on Thursday, September 14th. One analyst has rated the stock with a sell rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $32.20.

    View Our Latest Stock Analysis on SMTC

    Semtech Profile

    (Free Report)

    Semtech Corporation designs, develops, manufactures, and markets analog and mixed-signal semiconductor products and advanced algorithms. It provides signal integrity products, including a portfolio of optical data communications and video transport products used in various infrastructure, and industrial applications; a portfolio of integrated circuits for data centers, enterprise networks, passive optical networks, wireless base station optical transceivers, and high-speed interface applications; and video products for broadcast applications, as well as video-over-IP technology for professional audio video applications.

    Read More

    Want to see what other hedge funds are holding SMTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semtech Co. (NASDAQ:SMTC – Free Report).

    Institutional Ownership by Quarter for Semtech (NASDAQ:SMTC)

    Receive News & Ratings for Semtech Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Semtech and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in First Commonwealth Financial Co. (NYSE:FCF)

    Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in First Commonwealth Financial Co. (NYSE:FCF)

    Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of First Commonwealth Financial Co. (NYSE:FCF – Free Report) by 17.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,157 shares of the bank’s stock after acquiring an additional 7,905 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned 0.05% of First Commonwealth Financial worth $672,000 as of its most recent filing with the Securities and Exchange Commission.

    A number of other large investors have also modified their holdings of the stock. Tower Research Capital LLC TRC increased its holdings in First Commonwealth Financial by 173.9% in the first quarter. Tower Research Capital LLC TRC now owns 4,086 shares of the bank’s stock valued at $51,000 after buying an additional 2,594 shares during the last quarter. Metropolitan Life Insurance Co NY boosted its stake in First Commonwealth Financial by 14.1% in the fourth quarter. Metropolitan Life Insurance Co NY now owns 5,758 shares of the bank’s stock valued at $80,000 after acquiring an additional 710 shares in the last quarter. Ameritas Investment Partners Inc. boosted its stake in First Commonwealth Financial by 16.6% in the first quarter. Ameritas Investment Partners Inc. now owns 8,169 shares of the bank’s stock valued at $102,000 after acquiring an additional 1,164 shares in the last quarter. Captrust Financial Advisors boosted its stake in First Commonwealth Financial by 20.5% in the third quarter. Captrust Financial Advisors now owns 10,234 shares of the bank’s stock valued at $131,000 after acquiring an additional 1,739 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new position in First Commonwealth Financial in the second quarter valued at $136,000. Hedge funds and other institutional investors own 66.73% of the company’s stock.

    Wall Street Analysts Forecast Growth

    Several equities research analysts have recently weighed in on FCF shares. StockNews.com downgraded shares of First Commonwealth Financial from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Royal Bank of Canada cut their price target on shares of First Commonwealth Financial from $15.00 to $14.00 and set an “outperform” rating for the company in a report on Thursday, October 26th.

    Get Our Latest Analysis on First Commonwealth Financial

    First Commonwealth Financial Trading Up 0.1 %

    NYSE FCF opened at $14.09 on Thursday. First Commonwealth Financial Co. has a 52-week low of $11.16 and a 52-week high of $16.53. The company has a quick ratio of 0.93, a current ratio of 0.93 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $1.44 billion, a P/E ratio of 9.52 and a beta of 0.92. The firm has a 50-day moving average price of $12.75 and a 200 day moving average price of $13.08.

    First Commonwealth Financial (NYSE:FCF – Get Free Report) last released its earnings results on Tuesday, October 24th. The bank reported $0.39 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.01). First Commonwealth Financial had a net margin of 25.57% and a return on equity of 13.85%. The business had revenue of $164.71 million during the quarter, compared to analyst estimates of $123.21 million. During the same quarter in the previous year, the company posted $0.37 earnings per share. Equities research analysts expect that First Commonwealth Financial Co. will post 1.65 EPS for the current year.

    First Commonwealth Financial Announces Dividend

    The company also recently disclosed a quarterly dividend, which was paid on Friday, November 17th. Investors of record on Friday, November 3rd were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 3.55%. The ex-dividend date of this dividend was Thursday, November 2nd. First Commonwealth Financial’s dividend payout ratio is currently 33.78%.

    Insider Activity at First Commonwealth Financial

    In other news, EVP Carrie L. Riggle sold 7,563 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $13.21, for a total transaction of $99,907.23. Following the completion of the transaction, the executive vice president now directly owns 46,309 shares of the company’s stock, valued at $611,741.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.85% of the stock is owned by corporate insiders.

    About First Commonwealth Financial

    (Free Report)

    First Commonwealth Financial Corporation, a financial holding company, provides various consumer and commercial banking services in the United States. Its consumer services include personal checking accounts, interest-earning checking accounts, savings and health savings accounts, insured money market accounts, debit cards, investment certificates, fixed and variable rate certificates of deposit, mortgage loans, secured and unsecured installment loans, construction and real estate loans, safe deposit facilities, credit cards, credit lines with overdraft checking protection, IRA accounts, and automated teller machine (atm) services, as well as internet, mobile, and telephone banking services.

    Read More

    Want to see what other hedge funds are holding FCF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for First Commonwealth Financial Co. (NYSE:FCF – Free Report).

    Institutional Ownership by Quarter for First Commonwealth Financial (NYSE:FCF)

    Receive News & Ratings for First Commonwealth Financial Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for First Commonwealth Financial and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Rocket Lab USA, Inc. (NASDAQ:RKLB)

    Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Rocket Lab USA, Inc. (NASDAQ:RKLB)

    Mirae Asset Global Investments Co. Ltd. lifted its holdings in Rocket Lab USA, Inc. (NASDAQ:RKLB – Free Report) by 43.3% in the second quarter, HoldingsChannel reports. The firm owned 126,379 shares of the rocket manufacturer’s stock after purchasing an additional 38,177 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Rocket Lab USA were worth $758,000 at the end of the most recent reporting period.

    A number of other institutional investors and hedge funds have also recently modified their holdings of RKLB. Point72 Hong Kong Ltd purchased a new position in shares of Rocket Lab USA in the second quarter valued at $27,000. Tower Research Capital LLC TRC boosted its stake in Rocket Lab USA by 79.5% during the first quarter. Tower Research Capital LLC TRC now owns 10,014 shares of the rocket manufacturer’s stock worth $40,000 after buying an additional 4,435 shares during the period. Baxter Bros Inc. purchased a new position in Rocket Lab USA during the first quarter worth $40,000. PFG Investments LLC purchased a new position in Rocket Lab USA during the first quarter worth $42,000. Finally, Envestnet Asset Management Inc. purchased a new position in Rocket Lab USA during the fourth quarter worth $44,000. 54.19% of the stock is owned by hedge funds and other institutional investors.

    Insider Activity at Rocket Lab USA

    In related news, CEO Peter Beck sold 3,600,000 shares of Rocket Lab USA stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $5.62, for a total value of $20,232,000.00. Following the completion of the sale, the chief executive officer now directly owns 50,951,250 shares in the company, valued at $286,346,025. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Peter Beck sold 3,600,000 shares of Rocket Lab USA stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $5.62, for a total value of $20,232,000.00. Following the completion of the sale, the chief executive officer now directly owns 50,951,250 shares in the company, valued at $286,346,025. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Arjun Kampani sold 19,443 shares of Rocket Lab USA stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $4.46, for a total value of $86,715.78. Following the completion of the transaction, the general counsel now owns 505,947 shares in the company, valued at approximately $2,256,523.62. The disclosure for this sale can be found here. Insiders sold 3,677,164 shares of company stock worth $20,576,151 over the last three months. 15.00% of the stock is owned by corporate insiders.

    Rocket Lab USA Stock Down 2.8 %

    NASDAQ:RKLB opened at $4.45 on Wednesday. Rocket Lab USA, Inc. has a twelve month low of $3.48 and a twelve month high of $8.05. The company has a market cap of $2.16 billion, a price-to-earnings ratio of -12.36 and a beta of 1.17. The stock has a fifty day simple moving average of $4.35 and a 200-day simple moving average of $5.34. The company has a current ratio of 1.67, a quick ratio of 1.33 and a debt-to-equity ratio of 0.03.

    Rocket Lab USA (NASDAQ:RKLB – Get Free Report) last released its earnings results on Wednesday, November 8th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. The business had revenue of $67.66 million during the quarter, compared to the consensus estimate of $67.56 million. Rocket Lab USA had a negative return on equity of 26.98% and a negative net margin of 71.62%. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period last year, the company earned ($0.07) earnings per share. Analysts anticipate that Rocket Lab USA, Inc. will post -0.37 EPS for the current year.

    Analyst Ratings Changes

    Several research firms have commented on RKLB. Stifel Nicolaus dropped their price objective on shares of Rocket Lab USA from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Wednesday, September 27th. Citigroup dropped their price objective on shares of Rocket Lab USA from $7.40 to $5.75 in a research note on Wednesday, September 20th. Cantor Fitzgerald began coverage on shares of Rocket Lab USA in a research note on Thursday, October 26th. They set an “overweight” rating and a $6.00 price objective for the company. Wells Fargo & Company dropped their price objective on shares of Rocket Lab USA from $6.75 to $5.00 and set an “equal weight” rating for the company in a research note on Wednesday, September 20th. Finally, TD Cowen dropped their price objective on shares of Rocket Lab USA from $9.50 to $8.00 and set an “outperform” rating for the company in a research note on Wednesday, September 27th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $7.82.

    Read Our Latest Report on RKLB

    Rocket Lab USA Profile

    (Free Report)

    Rocket Lab USA, Inc, a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.

    See Also

    Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab USA, Inc. (NASDAQ:RKLB – Free Report).

    Institutional Ownership by Quarter for Rocket Lab USA (NASDAQ:RKLB)

    Receive News & Ratings for Rocket Lab USA Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Rocket Lab USA and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Dimensional Fund Advisors LP Purchases 434,908 Shares of MillerKnoll, Inc. (NASDAQ:MLKN)

    Dimensional Fund Advisors LP Purchases 434,908 Shares of MillerKnoll, Inc. (NASDAQ:MLKN)

    Dimensional Fund Advisors LP increased its stake in MillerKnoll, Inc. (NASDAQ:MLKN – Free Report) by 26.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,053,816 shares of the company’s stock after purchasing an additional 434,908 shares during the period. Dimensional Fund Advisors LP owned approximately 2.71% of MillerKnoll worth $30,355,000 as of its most recent filing with the SEC.

    Other hedge funds also recently modified their holdings of the company. US Bancorp DE bought a new position in shares of MillerKnoll in the first quarter worth $36,000. Captrust Financial Advisors bought a new position in shares of MillerKnoll in the first quarter worth $41,000. Point72 Hong Kong Ltd bought a new position in shares of MillerKnoll in the first quarter worth $58,000. Tower Research Capital LLC TRC increased its position in shares of MillerKnoll by 428.8% in the first quarter. Tower Research Capital LLC TRC now owns 2,168 shares of the company’s stock worth $44,000 after purchasing an additional 1,758 shares during the period. Finally, PNC Financial Services Group Inc. bought a new stake in MillerKnoll during the first quarter worth $103,000. Institutional investors own 88.66% of the company’s stock.

    Analyst Upgrades and Downgrades

    Several analysts recently weighed in on MLKN shares. Craig Hallum upped their price objective on MillerKnoll from $20.00 to $25.00 and gave the stock a “hold” rating in a research report on Wednesday, September 27th. StockNews.com initiated coverage on shares of MillerKnoll in a report on Thursday, October 5th. They issued a “buy” rating for the company.

    Read Our Latest Stock Analysis on MillerKnoll

    MillerKnoll Stock Performance

    NASDAQ MLKN opened at $27.17 on Tuesday. The firm’s fifty day moving average price is $24.44 and its two-hundred day moving average price is $19.68. The stock has a market cap of $2.00 billion, a PE ratio of 61.75, a PEG ratio of 1.07 and a beta of 1.30. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.89 and a current ratio of 1.56. MillerKnoll, Inc. has a fifty-two week low of $13.20 and a fifty-two week high of $27.46.

    MillerKnoll (NASDAQ:MLKN – Get Free Report) last announced its quarterly earnings results on Tuesday, September 26th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.16. MillerKnoll had a return on equity of 9.41% and a net margin of 0.84%. The company had revenue of $917.70 million during the quarter, compared to analysts’ expectations of $895.90 million. During the same period in the prior year, the company earned $0.44 EPS. MillerKnoll’s revenue was down 14.9% compared to the same quarter last year. On average, equities analysts expect that MillerKnoll, Inc. will post 2.07 EPS for the current fiscal year.

    MillerKnoll Announces Dividend

    The company also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Saturday, December 2nd will be paid a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a dividend yield of 2.76%. The ex-dividend date of this dividend is Thursday, November 30th. MillerKnoll’s payout ratio is 170.46%.

    MillerKnoll Company Profile

    (Free Report)

    MillerKnoll, Inc researches, designs, manufactures, and distributes interior furnishings worldwide. It operates through three segments: Americas Contract, International Contract & Specialty, and Global Retail. The company also provides seating products, furniture systems, other freestanding furniture elements, textiles, leather, felt, home furnishings and related services, casegoods, storage products, as well as residential, education, and healthcare furniture solutions.

    See Also

    Institutional Ownership by Quarter for MillerKnoll (NASDAQ:MLKN)

    Receive News & Ratings for MillerKnoll Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for MillerKnoll and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Mirae Asset Global Investments Co. Ltd. Purchases 640 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

    Mirae Asset Global Investments Co. Ltd. Purchases 640 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

    Mirae Asset Global Investments Co. Ltd. grew its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 3.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,324 shares of the company’s stock after purchasing an additional 640 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Amphastar Pharmaceuticals were worth $1,053,000 as of its most recent filing with the SEC.

    A number of other hedge funds have also bought and sold shares of the company. Point72 Middle East FZE bought a new stake in Amphastar Pharmaceuticals in the fourth quarter worth approximately $50,000. Pacer Advisors Inc. bought a new stake in Amphastar Pharmaceuticals in the second quarter valued at $59,000. Point72 Hong Kong Ltd acquired a new position in shares of Amphastar Pharmaceuticals during the first quarter valued at about $74,000. Tower Research Capital LLC TRC boosted its position in shares of Amphastar Pharmaceuticals by 206.9% during the 1st quarter. Tower Research Capital LLC TRC now owns 1,998 shares of the company’s stock worth $75,000 after purchasing an additional 1,347 shares in the last quarter. Finally, Captrust Financial Advisors grew its stake in shares of Amphastar Pharmaceuticals by 114.4% in the 1st quarter. Captrust Financial Advisors now owns 2,770 shares of the company’s stock valued at $99,000 after buying an additional 1,478 shares during the period. Institutional investors own 65.09% of the company’s stock.

    Amphastar Pharmaceuticals Price Performance

    AMPH stock opened at $57.92 on Monday. The company has a market capitalization of $2.77 billion, a P/E ratio of 22.63, a price-to-earnings-growth ratio of 0.88 and a beta of 0.92. Amphastar Pharmaceuticals, Inc. has a 52-week low of $27.58 and a 52-week high of $67.66. The business has a 50-day simple moving average of $49.34 and a two-hundred day simple moving average of $51.83. The company has a debt-to-equity ratio of 1.07, a quick ratio of 1.68 and a current ratio of 2.11.

    Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) last released its quarterly earnings results on Wednesday, November 8th. The company reported $1.08 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.41. Amphastar Pharmaceuticals had a return on equity of 26.68% and a net margin of 22.50%. The business had revenue of $180.56 million during the quarter, compared to analyst estimates of $170.65 million. Research analysts expect that Amphastar Pharmaceuticals, Inc. will post 2.91 EPS for the current fiscal year.

    Wall Street Analyst Weigh In

    AMPH has been the topic of several recent research reports. StockNews.com lowered Amphastar Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Tuesday, November 21st. Bank of America began coverage on Amphastar Pharmaceuticals in a report on Friday, November 17th. They issued a “neutral” rating and a $63.00 target price on the stock. Finally, Piper Sandler boosted their price target on shares of Amphastar Pharmaceuticals from $66.00 to $71.00 in a research note on Wednesday, August 9th.

    Check Out Our Latest Stock Analysis on Amphastar Pharmaceuticals

    Insider Activity

    In related news, CFO William J. Peters sold 60,743 shares of the business’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $51.75, for a total transaction of $3,143,450.25. Following the transaction, the chief financial officer now directly owns 101,360 shares in the company, valued at $5,245,380. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Amphastar Pharmaceuticals news, Director Richard K. Prins sold 5,000 shares of the business’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $52.50, for a total value of $262,500.00. Following the transaction, the director now owns 35,895 shares of the company’s stock, valued at $1,884,487.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO William J. Peters sold 60,743 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $51.75, for a total value of $3,143,450.25. Following the completion of the transaction, the chief financial officer now owns 101,360 shares of the company’s stock, valued at approximately $5,245,380. The disclosure for this sale can be found here. Insiders sold a total of 70,743 shares of company stock worth $3,674,930 over the last quarter. Insiders own 28.40% of the company’s stock.

    Amphastar Pharmaceuticals Company Profile

    (Free Report)

    Amphastar Pharmaceuticals, Inc, a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API).

    Featured Stories

    Institutional Ownership by Quarter for Amphastar Pharmaceuticals (NASDAQ:AMPH)

    Receive News & Ratings for Amphastar Pharmaceuticals Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Amphastar Pharmaceuticals and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • BNP Paribas Arbitrage SNC Has $804,000 Stake in Zuora, Inc. (NYSE:ZUO)

    BNP Paribas Arbitrage SNC Has $804,000 Stake in Zuora, Inc. (NYSE:ZUO)

    BNP Paribas Arbitrage SNC trimmed its stake in shares of Zuora, Inc. (NYSE:ZUO – Free Report) by 9.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,313 shares of the company’s stock after selling 7,372 shares during the period. BNP Paribas Arbitrage SNC’s holdings in Zuora were worth $804,000 as of its most recent SEC filing.

    Other hedge funds and other institutional investors have also made changes to their positions in the company. Nisa Investment Advisors LLC raised its holdings in shares of Zuora by 8,200.0% during the first quarter. Nisa Investment Advisors LLC now owns 3,320 shares of the company’s stock worth $33,000 after acquiring an additional 3,280 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of Zuora by 164.0% during the third quarter. Tower Research Capital LLC TRC now owns 8,629 shares of the company’s stock worth $63,000 after acquiring an additional 5,360 shares during the period. Envestnet Asset Management Inc. acquired a new stake in shares of Zuora during the third quarter worth $76,000. Point72 Middle East FZE acquired a new stake in shares of Zuora during the fourth quarter worth $83,000. Finally, Delphia USA Inc. acquired a new stake in shares of Zuora during the first quarter worth $103,000. 72.42% of the stock is currently owned by institutional investors and hedge funds.

    Zuora Stock Down 1.2 %

    Shares of ZUO stock opened at $9.01 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 1.90. Zuora, Inc. has a 1 year low of $5.45 and a 1 year high of $12.12. The firm’s fifty day moving average price is $7.97 and its two-hundred day moving average price is $9.44. The firm has a market capitalization of $1.27 billion, a P/E ratio of -15.53 and a beta of 1.88.

    Zuora (NYSE:ZUO – Get Free Report) last released its quarterly earnings data on Wednesday, November 29th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.06. The company had revenue of $109.80 million for the quarter, compared to analyst estimates of $108.66 million. Zuora had a negative net margin of 18.68% and a negative return on equity of 67.87%. Zuora’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.24) EPS. On average, equities analysts predict that Zuora, Inc. will post -0.55 EPS for the current fiscal year.

    Wall Street Analyst Weigh In

    Several brokerages have issued reports on ZUO. Needham & Company LLC reiterated a “buy” rating and issued a $15.00 price target on shares of Zuora in a research note on Thursday. Canaccord Genuity Group reiterated a “buy” rating and issued a $16.00 price target on shares of Zuora in a research note on Thursday. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.86.

    View Our Latest Research Report on Zuora

    Insider Transactions at Zuora

    In other news, insider Andrew M. Cohen sold 3,844 shares of the business’s stock in a transaction dated Wednesday, September 20th. The shares were sold at an average price of $8.68, for a total transaction of $33,365.92. Following the transaction, the insider now directly owns 76,139 shares in the company, valued at approximately $660,886.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Zuora news, insider Andrew M. Cohen sold 3,128 shares of the business’s stock in a transaction dated Friday, October 6th. The shares were sold at an average price of $8.00, for a total value of $25,024.00. Following the completion of the sale, the insider now owns 107,942 shares of the company’s stock, valued at approximately $863,536. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Andrew M. Cohen sold 3,844 shares of the business’s stock in a transaction dated Wednesday, September 20th. The shares were sold at an average price of $8.68, for a total transaction of $33,365.92. Following the completion of the sale, the insider now directly owns 76,139 shares of the company’s stock, valued at approximately $660,886.52. The disclosure for this sale can be found here. Insiders have sold 460,850 shares of company stock worth $3,775,153 in the last ninety days. Insiders own 9.25% of the company’s stock.

    Zuora Profile

    (Free Report)

    Zuora, Inc, together with its subsidiaries, provides cloud-based subscription management platform that enables companies in various industries to launch, manage, and transform into a subscription business. The company offers Zuora platform that acts as an orchestration engine that allows customers quote-to-cash and revenue operations; and Zuora Billing that helps customers to set payment terms, manage hierarchical billing relationships, consolidate invoicing across multiple subscriptions, and tax transactions.

    Read More

    Want to see what other hedge funds are holding ZUO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zuora, Inc. (NYSE:ZUO – Free Report).

    Institutional Ownership by Quarter for Zuora (NYSE:ZUO)

    Receive News & Ratings for Zuora Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Zuora and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Cetera Investment Advisers Has $330,000 Stock Position in Five Below, Inc. (NASDAQ:FIVE)

    Cetera Investment Advisers Has $330,000 Stock Position in Five Below, Inc. (NASDAQ:FIVE)

    Cetera Investment Advisers reduced its stake in shares of Five Below, Inc. (NASDAQ:FIVE – Free Report) by 4.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,681 shares of the specialty retailer’s stock after selling 80 shares during the quarter. Cetera Investment Advisers’ holdings in Five Below were worth $330,000 as of its most recent SEC filing.

    Several other large investors also recently modified their holdings of the stock. BlackRock Inc. boosted its stake in Five Below by 1.0% in the first quarter. BlackRock Inc. now owns 4,879,733 shares of the specialty retailer’s stock valued at $1,005,079,000 after buying an additional 46,515 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Five Below by 2,513.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,892,692 shares of the specialty retailer’s stock valued at $801,779,000 after buying an additional 3,743,768 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in Five Below by 10.5% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,730,378 shares of the specialty retailer’s stock valued at $482,922,000 after buying an additional 259,012 shares in the last quarter. Wasatch Advisors Inc. boosted its stake in Five Below by 21.4% in the first quarter. Wasatch Advisors Inc. now owns 2,676,533 shares of the specialty retailer’s stock valued at $423,883,000 after buying an additional 471,349 shares in the last quarter. Finally, State Street Corp boosted its stake in Five Below by 2.5% in the first quarter. State Street Corp now owns 1,528,420 shares of the specialty retailer’s stock valued at $314,809,000 after buying an additional 37,025 shares in the last quarter.

    Five Below Stock Performance

    Shares of FIVE stock opened at $188.46 on Friday. The company has a market cap of $10.50 billion, a P/E ratio of 38.70, a PEG ratio of 1.69 and a beta of 1.18. The stock has a 50 day simple moving average of $172.93 and a two-hundred day simple moving average of $182.24. Five Below, Inc. has a fifty-two week low of $144.57 and a fifty-two week high of $220.19.

    Five Below (NASDAQ:FIVE – Get Free Report) last issued its earnings results on Wednesday, November 29th. The specialty retailer reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.03. The business had revenue of $736.41 million during the quarter, compared to the consensus estimate of $728.04 million. Five Below had a return on equity of 20.23% and a net margin of 8.35%. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.29 earnings per share. On average, research analysts predict that Five Below, Inc. will post 5.46 earnings per share for the current year.

    Insiders Place Their Bets

    In other news, CEO Joel D. Anderson acquired 3,100 shares of Five Below stock in a transaction on Friday, September 8th. The stock was purchased at an average price of $161.50 per share, with a total value of $500,650.00. Following the completion of the purchase, the chief executive officer now owns 99,656 shares of the company’s stock, valued at approximately $16,094,444. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.80% of the stock is currently owned by corporate insiders.

    Wall Street Analyst Weigh In

    FIVE has been the topic of several research analyst reports. StockNews.com initiated coverage on Five Below in a research note on Thursday, October 5th. They issued a “sell” rating on the stock. Guggenheim reiterated a “buy” rating and issued a $220.00 target price on shares of Five Below in a research report on Friday, September 1st. Telsey Advisory Group reiterated an “outperform” rating and issued a $220.00 target price on shares of Five Below in a research report on Monday. Citigroup increased their target price on Five Below from $220.00 to $227.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Loop Capital dropped their target price on Five Below from $200.00 to $175.00 and set a “hold” rating for the company in a research report on Thursday, August 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nineteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $218.52.

    View Our Latest Stock Analysis on Five Below

    About Five Below

    (Free Report)

    Five Below, Inc operates as a specialty value retailer in the United States. The company offers range of accessories, which includes novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories, athletic tops and bottoms, and t-shirts, as well as nail polish, lip gloss, fragrance, and branded cosmetics; and personalized living space products, such as glitter lamps, posters, frames, fleece blankets, plush items, pillows, candles, incense, lighting, novelty décor, accent furniture, and related items, as well as provides storage options.

    Featured Articles

    Want to see what other hedge funds are holding FIVE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Five Below, Inc. (NASDAQ:FIVE – Free Report).

    Institutional Ownership by Quarter for Five Below (NASDAQ:FIVE)

    Receive News & Ratings for Five Below Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Five Below and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $845,000 Holdings in Tripadvisor, Inc. (NASDAQ:TRIP)

    Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $845,000 Holdings in Tripadvisor, Inc. (NASDAQ:TRIP)

    Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of Tripadvisor, Inc. (NASDAQ:TRIP – Free Report) by 8.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 51,256 shares of the travel company’s stock after purchasing an additional 4,061 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Tripadvisor were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.

    Other institutional investors also recently modified their holdings of the company. Dark Forest Capital Management LP grew its holdings in shares of Tripadvisor by 1,227.3% during the 1st quarter. Dark Forest Capital Management LP now owns 1,699 shares of the travel company’s stock worth $34,000 after purchasing an additional 1,571 shares in the last quarter. Harvest Fund Management Co. Ltd boosted its stake in Tripadvisor by 1,581.0% in the 1st quarter. Harvest Fund Management Co. Ltd now owns 4,068 shares of the travel company’s stock valued at $81,000 after buying an additional 3,826 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in Tripadvisor in the 1st quarter valued at $99,000. Quent Capital LLC boosted its stake in Tripadvisor by 15,625.0% in the 2nd quarter. Quent Capital LLC now owns 5,032 shares of the travel company’s stock valued at $83,000 after buying an additional 5,000 shares in the last quarter. Finally, Advisory Services Network LLC boosted its stake in Tripadvisor by 665.7% in the 1st quarter. Advisory Services Network LLC now owns 7,833 shares of the travel company’s stock valued at $156,000 after buying an additional 6,810 shares in the last quarter. Institutional investors and hedge funds own 74.17% of the company’s stock.

    Analyst Ratings Changes

    Several brokerages recently commented on TRIP. Mizuho decreased their price target on Tripadvisor from $20.00 to $18.00 and set a “neutral” rating on the stock in a research note on Friday, August 4th. Wells Fargo & Company boosted their price target on Tripadvisor from $17.00 to $20.00 and gave the company an “equal weight” rating in a research note on Friday, August 4th. Sanford C. Bernstein raised Tripadvisor from a “market perform” rating to an “outperform” rating in a research note on Monday, November 13th. TD Cowen reduced their price objective on Tripadvisor from $18.00 to $16.00 and set a “market perform” rating on the stock in a research note on Monday, August 14th. Finally, StockNews.com raised Tripadvisor from a “hold” rating to a “buy” rating in a research note on Wednesday, November 15th. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $20.56.

    View Our Latest Report on TRIP

    Tripadvisor Trading Down 3.7 %

    TRIP stock opened at $17.91 on Thursday. The company has a market cap of $2.48 billion, a P/E ratio of -99.50 and a beta of 1.43. Tripadvisor, Inc. has a twelve month low of $14.15 and a twelve month high of $27.30. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 1.08. The business has a fifty day moving average of $16.54 and a 200-day moving average of $16.37.

    Tripadvisor (NASDAQ:TRIP – Get Free Report) last released its quarterly earnings data on Monday, November 6th. The travel company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.03. The business had revenue of $533.00 million during the quarter, compared to the consensus estimate of $506.01 million. Tripadvisor had a positive return on equity of 8.64% and a negative net margin of 1.43%. As a group, equities research analysts expect that Tripadvisor, Inc. will post 0.47 EPS for the current year.

    Tripadvisor Profile

    (Free Report)

    TripAdvisor, Inc operates as an online travel company, primarily engages in the provision of travel guidance products and services worldwide. The company operates in three segments: Tripadvisor Core, Viator, and TheFork. The Tripadvisor Core segment offers travel guidance platforms for travelers to discover, generate, and share authentic user-generated content in the form of ratings and reviews for destinations, points-of-interest, experiences, accommodations, restaurants, and cruises.

    Featured Stories

    Want to see what other hedge funds are holding TRIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tripadvisor, Inc. (NASDAQ:TRIP – Free Report).

    Institutional Ownership by Quarter for Tripadvisor (NASDAQ:TRIP)

    Receive News & Ratings for Tripadvisor Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tripadvisor and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link